HighTower Advisors’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.58M Buy
1,101,502
+537,761
+95% +$1.32M ﹤0.01% 1632
2026
Q2
$733K Buy
563,741
+1,371
+0.2% +$2K ﹤0.01% 2449
2026
Q1
$815K Sell
562,370
-1,936
-0.3% -$3.07K ﹤0.01% 2340
2025
Q4
$779K Sell
564,306
-12,763
-2% -$26.7K ﹤0.01% 2297
2025
Q3
$1.58M Buy
577,069
+417,087
+261% +$1.48M ﹤0.01% 1780
2025
Q2
$558K Buy
159,982
+4,000
+3% +$15.8K ﹤0.01% 2426
2025
Q1
$574K Sell
155,982
-88,900
-36% -$325K ﹤0.01% 2346
2024
Q4
$394K Sell
244,882
-1,100
-0.4% -$1.14K ﹤0.01% 2668
2024
Q3
$187K Buy
245,982
+87,816
+56% +$115K ﹤0.01% 3159
2024
Q2
$285K Hold
158,166
– – ﹤0.01% 2755
2024
Q1
$753K Sell
158,166
-25,000
-14% -$87.9K ﹤0.01% 1987
2023
Q4
$531K Buy
183,166
+26,000
+17% +$41K ﹤0.01% 2277
2023
Q3
$212K Buy
157,166
+3,537
+2% +$6.2K ﹤0.01% 2869
2023
Q2
$330K Hold
153,629
– – ﹤0.01% 2505
2023
Q1
$446K Hold
153,629
– – ﹤0.01% 2191
2022
Q4
$1.06M Hold
153,629
– – ﹤0.01% 1642
2022
Q3
$489K Buy
153,629
+56,700
+58% +$206K ﹤0.01% 2048
2022
Q2
$312K Hold
96,929
– – ﹤0.01% 2331
2022
Q1
$294K Sell
96,929
-20
-0% -$68 ﹤0.01% 2541
2021
Q4
$432K Buy
96,949
+20
+0% +$98 ﹤0.01% 2247
2021
Q3
$635K Buy
96,929
+22,675
+31% +$217K ﹤0.01% 1917
2021
Q2
$1.19M Hold
74,254
– – ﹤0.01% 1534
2021
Q1
$919K Hold
74,254
– – ﹤0.01% 1619
2020
Q4
$825K Sell
74,254
-68,000
-48% -$511K ﹤0.01% 1365
2020
Q3
$691K Buy
+142,254
New +$540K ﹤0.01% 1403

Other funds holding STIM

HighTower Advisors's STIM Position: Q3 2026 in Review

HighTower Advisors increased its Neuronetics (STIM) stake by 95% in Q3 2026, buying an estimated $1.32M and bringing the position to 1,101,502 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

HighTower Advisors first reported a position in STIM in Q3 2020 and has held it in 25 quarters since. 28 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • HighTower Advisors held 1,101,502 shares of Neuronetics worth $2.58M as of Q3 2026.
  • HighTower Advisors bought 537,761 Neuronetics shares in Q3 2026, an estimated $1.32M.
  • Neuronetics made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #1632 holding.
  • HighTower Advisors first reported a position in Neuronetics in Q3 2020 and has held it in 25 quarters since.
  • 28 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.